These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits. McKeown L; Robinson P; Jones OT Acta Pharmacol Sin; 2006 Jul; 27(7):799-812. PubMed ID: 16787562 [TBL] [Abstract][Full Text] [Related]
5. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. Flink MT; Atchison WD J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529 [TBL] [Abstract][Full Text] [Related]
6. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. Restituito S; Thompson RM; Eliet J; Raike RS; Riedl M; Charnet P; Gomez CM J Neurosci; 2000 Sep; 20(17):6394-403. PubMed ID: 10964945 [TBL] [Abstract][Full Text] [Related]
7. Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. Hansen PB; Poulsen CB; Walter S; Marcussen N; Cribbs LL; Skøtt O; Jensen BL Hypertension; 2011 Sep; 58(3):464-70. PubMed ID: 21788606 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. Giovannini F; Sher E; Webster R; Boot J; Lang B Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346 [TBL] [Abstract][Full Text] [Related]
9. Calcium channels in neurological disease. Greenberg DA Ann Neurol; 1997 Sep; 42(3):275-82. PubMed ID: 9307247 [TBL] [Abstract][Full Text] [Related]
10. Calcium channels and channelopathies of the central nervous system. Pietrobon D Mol Neurobiol; 2002 Feb; 25(1):31-50. PubMed ID: 11890456 [TBL] [Abstract][Full Text] [Related]
11. Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels. Bidaud I; Lory P Biochimie; 2011 Dec; 93(12):2080-6. PubMed ID: 21664226 [TBL] [Abstract][Full Text] [Related]
12. Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. Barrett CF; Cao YQ; Tsien RW J Biol Chem; 2005 Jun; 280(25):24064-71. PubMed ID: 15795222 [TBL] [Abstract][Full Text] [Related]
13. Neuromuscular disease and calcium channels. Greenberg DA Muscle Nerve; 1999 Oct; 22(10):1341-9. PubMed ID: 10487899 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. Martín-García E; Mannara F; Gutiérrez-Cuesta J; Sabater L; Dalmau J; Maldonado R; Graus F J Neuroimmunol; 2013 Aug; 261(1-2):53-9. PubMed ID: 23726906 [TBL] [Abstract][Full Text] [Related]
18. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports. Schneider I; Kornhuber ME; Hanisch F J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033 [TBL] [Abstract][Full Text] [Related]
19. Decoding of synaptic voltage waveforms by specific classes of recombinant high-threshold Ca(2+) channels. Liu Z; Ren J; Murphy TH J Physiol; 2003 Dec; 553(Pt 2):473-88. PubMed ID: 14500770 [TBL] [Abstract][Full Text] [Related]
20. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]